Tag: American Academy of Allergy Asthma and Immunology (AAAAI)

The Stones - OAS

Oral Allergy Syndrome: What it is, What to Avoid

If you suffer from seasonal allergies and your mouth itches when eating certain fruits and vegetables, you may have OAS.
AAAAI Logo + Palforzia

AAAAI Addresses What Patients and Their Families Need to Know About...

As the FDA moves closer to approving the first food allergy treatment, the AAAAI seeks to help patients and their families understand the realities surrounding OIT.
Paramedics

Study: Emergency Department Visits for Anaphylaxis have Skyrocketed Since 2008

Study reveals visits increased 3.2-fold among children from 2008 to 2016 and 1.9-fold among adults.
Red Meat

Q&A: Everything You Need to Know About Alpha-gal Syndrome, the Meat...

What it is, what it does, how you catch it and how you prevent it.
Summer Camp

Off to Camp with Food Allergies: Don’t Forget the Emergency Action...

The plan provides specific instructions regarding how to identify the symptoms of a reaction and steps to follow.
Air Travel

Stocking Epinephrine Auto-Injectors on Commercial Flights Found to be Cost-Effective

According to this study, base-case scenarios demonstrate the annual cost per passenger-at-risk would be $0.08.
Research

Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...

Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
Epinephrine Auto-Injectors

Epinephrine Auto-injectors Retain High Levels of Epinephrine Years After Expiration Date,...

Study shows majority of epinephrine auto-injectors retained over 90% concentration of epinephrine years after expiration dates, regardless of the manufacturer.
Eggs

Egg OIT Leads to More Rapid Allergy Desensitization Than Baked-Egg Products

Study suggests oral immunotherapy may lead to higher sustained unresponsiveness to egg for baked-egg tolerant children.
AR101

Aimmune Therapeutics Presents New AR101 Data Including Demonstrated Reduction in Accidental...

AR101-Treated Patients Who Completed PALISADE Had 95% Increased Probability of Tolerating Any Dose of Peanut Protein in Exit Challenge Compared to Placebo.

Connect with Us

40,535FansLike
1,020FollowersFollow
2,772FollowersFollow
5,628FollowersFollow
45SubscribersSubscribe